253 related articles for article (PubMed ID: 29281972)
1. Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure.
Fookes MC; Hadfield J; Harris S; Parmar S; Unemo M; Jensen JS; Thomson NR
BMC Genomics; 2017 Dec; 18(1):993. PubMed ID: 29281972
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiological analysis of
Laumen JGE; van Alphen LB; Maduna LD; Hoffman CM; Klausner JD; Medina-Marino A; Kock MM; Peters RPH
Sex Transm Infect; 2021 Mar; 97(2):152-156. PubMed ID: 32389900
[TBL] [Abstract][Full Text] [Related]
3. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
[TBL] [Abstract][Full Text] [Related]
4. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
[TBL] [Abstract][Full Text] [Related]
5. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
[TBL] [Abstract][Full Text] [Related]
6. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant Mycoplasma genitalium infections in Europe.
Braam JF; van Dommelen L; Henquet CJM; van de Bovenkamp JHB; Kusters JG
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1565-1567. PubMed ID: 28361246
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan.
Deguchi T; Yasuda M; Horie K; Seike K; Kikuchi M; Mizutani K; Tsuchiya T; Yokoi S; Nakano M; Hoshina S
Emerg Infect Dis; 2015 Jun; 21(6):1062-4. PubMed ID: 25988775
[TBL] [Abstract][Full Text] [Related]
9. A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium.
Plummer EL; Murray GL; Bodiyabadu K; Su J; Garland SM; Bradshaw CS; Read TRH; Tabrizi SN; Danielewski JA
J Microbiol Methods; 2020 Dec; 179():106089. PubMed ID: 33184030
[TBL] [Abstract][Full Text] [Related]
10. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
[TBL] [Abstract][Full Text] [Related]
11. mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences.
Iverson-Cabral SL; Astete SG; Cohen CR; Totten PA
Mol Microbiol; 2007 Oct; 66(1):55-73. PubMed ID: 17880423
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Shipitsyna E; Rumyantseva T; Golparian D; Khayrullina G; Lagos AC; Edelstein I; Joers K; Jensen JS; Savicheva A; Rudneva N; Sukhanova L; Kozlov R; Guschin A; Unemo M
PLoS One; 2017; 12(4):e0175763. PubMed ID: 28407014
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome.
Ma L; Jensen JS; Myers L; Burnett J; Welch M; Jia Q; Martin DH
Mol Microbiol; 2007 Oct; 66(1):220-36. PubMed ID: 17784912
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
Fernández-Huerta M; Bodiyabadu K; Esperalba J; Bradshaw CS; Serra-Pladevall J; Garland SM; Fernández-Naval C; Jensen JS; Pumarola T; Ebeyan S; Lundgren M; Tan LY; Espasa M; Murray GL
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434719
[No Abstract] [Full Text] [Related]
17. Draft genome sequences of four axenic Mycoplasma genitalium strains isolated from Denmark, Japan, and Australia.
McGowin CL; Ma L; Jensen JS; Mancuso MM; Hamasuna R; Adegboye D; Martin DH
J Bacteriol; 2012 Nov; 194(21):6010-1. PubMed ID: 23045512
[TBL] [Abstract][Full Text] [Related]
18. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of macrolide- and fluoroquinolone-resistant Mycoplasma genitalium strains in clinical specimens from men who have sex with men of two sexually transmitted infection practices in Berlin, Germany.
Dumke R; Ziegler T; Abbasi-Boroudjeni N; Rust M; Glaunsinger T
J Glob Antimicrob Resist; 2019 Sep; 18():118-121. PubMed ID: 31252154
[TBL] [Abstract][Full Text] [Related]
20. Detection of markers predictive of macrolide and fluoroquinolone resistance in
Pitt R; Fifer H; Woodford N; Alexander S
Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
